Explore more Norwegian companies →
COMPANY CARD COMPANY
VITAS AS
Diagnostic imaging services and medical laboratory activities
40,2 % EBIT margin
FINANCIALS
Financial statements and key figures
Company financial statements
Amount in NOK
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Currency | NOK | NOK | NOK | NOK | NOK |
| Operating revenue | 89 792 519 | 77 625 607 | 64 025 129 | 49,407,000 | 49,236,000 |
| Operating profit | 36 066 120 | 28 791 733 | 19 287 544 | 11,386,000 | 11,728,000 |
| Net income | 28 604 039 | 23 157 385 | 15 292 277 | 9,564,000 | 9,536,000 |
| Equity | 3 619 784 | 3 281 104 | 5 393 136 | 9,344,000 | 9,307,000 |
| Total assets | 44 190 199 | 41 364 241 | 34 985 734 | 30,384,000 | 28,731,000 |
| Total liabilities | 40 570 414 | 38 083 137 | 29 592 598 | 21,040,000 | 19,424,000 |
| EBIT margin | 40,2 % | 37,1 % | 30,1 % | 23,0 % | 23,8 % |
Historical company accounts in NOK. The source identifies the year. A dash indicates an unavailable amount.
Indicators: equity / assets and EBIT / operating revenue. Midline is 0%, scale −100% to +100%. Not a credit assessment.
Show trend in NOK
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Click the year markers for exact amounts. Missing years create gaps. The financial statement table above shows all amounts.
Sources and conversion basis
Companies and corporate groups are kept separate. The same historical annual exchange rate is used for income statement and balance sheet figures. Missing values are shown as “—”. Actual zero values are retained.
- 2025 · NOK · original-NOK · source version e7843804607f
- 2024 · NOK · original-NOK · source version 599343302f80
- 2023 · NOK · original-NOK · source version f9ea63d929e4
Expand for more financial statement items. We show items with information in at least one year. “—” means a value is missing for that year.
Income statement13 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating revenue | |||||
| Total sales revenue | 89 792 519 | 77 625 607 | 64 025 129 | 49,407,000 | 49,236,000 |
| Total operating revenue | 89 792 519 | 77 625 607 | 64 025 129 | 49,407,000 | 49,236,000 |
| Operating expenses | |||||
| Wage costs | 30 312 863 | 27 796 597 | 26 030 384 | 22,891,000 | 21,473,000 |
| Total operating expenses | 53 726 398 | 48 833 873 | 44 737 585 | — | — |
| Operating profit | |||||
| Operating income (EBIT) | 36 066 120 | 28 791 733 | 19 287 544 | 11,386,000 | 11,728,000 |
| Financial income | |||||
| Total finance income | 738 787 | 623 042 | 77 806 | 402,000 | 37,000 |
| Financial expenses | |||||
| Other interest expense | 16 395 | 13 795 | 28 676 | 16,000 | 39,000 |
| Total finance costs | 139 546 | 129 860 | 157 437 | 112,000 | 110,000 |
| Net finance result | 599 240 | 493 182 | -79 631 | — | — |
| Results and tax | |||||
| Income before tax | 36 665 361 | 29 284 915 | 19 207 913 | 11,675,000 | 11,655,000 |
| Tax expense on ordinary income | 8 061 322 | 6 127 530 | 3 915 636 | 2,111,000 | 2,119,000 |
| Net income | 28 604 039 | 23 157 385 | 15 292 277 | 9,564,000 | 9,536,000 |
| Total comprehensive income | 28 604 039 | 23 157 385 | 15 292 277 | — | — |
Balance sheet12 entries with information
| Financial statement item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Financial fixed assets | |||||
| Total non-current assets | 1 693 951 | 1 669 780 | 1 862 726 | 5,559,000 | 3,307,000 |
| Current assets | |||||
| Total receivables | 21 807 672 | 19 105 994 | 15 306 065 | 11,636,000 | 9,415,000 |
| Total cash and cash equivalents | 20 688 576 | 20 588 467 | 17 816 943 | 13,190,000 | 16,010,000 |
| Total current assets | 42 496 248 | 39 694 461 | 33 123 008 | 24,825,000 | 25,424,000 |
| Total assets | 44 190 199 | 41 364 241 | 34 985 734 | 30,384,000 | 28,731,000 |
| Equity | |||||
| Total paid-in equity | 3 226 632 | 3 226 632 | 1 515 481 | 1,515,000 | 1,515,000 |
| Total retained earnings | 393 153 | 54 472 | 3 877 655 | 7,829,000 | 7,792,000 |
| Total equity | 3 619 784 | 3 281 104 | 5 393 136 | 9,344,000 | 9,307,000 |
| Provisions and long-term liabilities | |||||
| Total long-term liabilities | — | 0 | 0 | — | — |
| Current liabilities | |||||
| Total current liabilities | 40 570 414 | 38 083 137 | 29 592 598 | 21,040,000 | 19,424,000 |
| Total liabilities | 40 570 414 | 38 083 137 | 29 592 598 | 21,040,000 | 19,424,000 |
| Total | |||||
| Total equity and liabilities | 44 190 199 | 41 364 241 | 34 985 734 | 30,384,000 | 28,731,000 |
Some amounts for 2021 and 2022 come from a financial statements archive and are rounded to the nearest NOK 1,000. The source does not specify reporting dates or whether these figures cover the company or a group.
Reported dividends
| Financial year | Dividends – Income statement | Dividends – Balance sheet | Accounting scope |
|---|---|---|---|
| 2025 | 23 126 000 NOK | 23 126 000 NOK | Not stated |
| 2024 | 23 126 000 NOK | 23 126 000 NOK | Not stated |
| 2023 | 15 244 000 NOK | 15 244 000 NOK | Not stated |
| 2022 | 9 527 000 NOK | 9 527 000 NOK | Not stated |
| 2021 | 9 527 000 NOK | 9 527 000 NOK | Not stated |
| 2020 | 9 718 000 NOK | 9 718 000 NOK | Company financial statements |
Income statement and balance sheet are separate accounting fields and must not be added together. “—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene
Executive salary
| Financial year | Reported CEO salary |
|---|---|
| 2025 | — |
| 2024 | — |
| 2023 | — |
| 2022 | — |
| 2021 | — |
| 2020 | 1 877 000 NOK |
“—” means that no amount is available for the year. It does not mean the amount is zero.
Source: Brønnøysundregistrene · Amount in NOK
REGISTRY INFORMATION
Company at a glance
- Industry
- 86.910 · Diagnostic imaging services and medical laboratory activities Industry classification: Statistics Norway · CC BY 4.0
- Registered address
- Gaustadalléen 21, 0349 OSLO
- Founded
- 10.01.1994
- Entity type
- Main entity
ADDRESS AND PROPERTY
Property information
Gaustadalléen 21, 0349 OSLO
Companies at the same address
Available company cards
About the address match
Same registered street address, postal code, and municipality. This does not document ownership, tenancy, or who uses the building. The address match does not identify a specific unit or dwelling. Open information does not show titleholders, sale date, plot area, or a complete building overview.
REGISTERED ROLES
The people and companies behind it.
| Name | Role | Source date |
|---|---|---|
| Tore Odin BolstadBorn 1966 | Board member | 20.11.2026 |
| Thomas Erik GundersenBorn 1967 | General manager | 20.11.2026 |
| Linni TillerBorn 1960 | Chair of the board | 20.11.2026 |
| REVISORFORUM 1 ASView role record | Auditor | 20.11.2026 |
| Christian André DrevonBorn 1945 | Board member | 20.11.2026 |
| VIEW GROUP ASView role record | Accountant | 20.11.2026 |
Source: Brønnøysund Register Centre. A registered role is not documentation of direct contact information.
YEAR-DATED OWNERSHIP
Reported shareholders.
As of 31 December 2025 · 10 of 35 available ownership entries
- DBG ASOrdinary shares24,15 %
- REDOKS ASOrdinary shares22,66 %
- THOMAS ERIK GUNDERSENOrdinary shares15,08 %
- BJARNE BORGERSENOrdinary shares6,40 %
- TEG HOLDING ASOrdinary shares4,43 %
- Other / undisplayed records27,28 %
Fixed scale 0–100%. Shares are not normalized. Any unfilled portion is outside the displayed total.
Multiple company owners (2)
| Shareholder | Share / share class | Source date |
|---|---|---|
| VAR FORVALTNING ASView ownership entryView share entries → | 0,78 % · Ordinary shares | 31.12.2025 |
| PHARMCONSULT ASView ownership entryView share entries → | 0,64 % · Ordinary shares | 31.12.2025 |
Source: Skatteetaten. Ownership share is a share of the number of shares, not necessarily voting rights or control. Person names refer to separate source records. Similar names are not automatically the same person.
Previously reported ownership entries (63)
- 2024 · DBG AS · 24,15 %
- 2024 · REDOKS AS · 22,66 %
- 2024 · THOMAS ERIK GUNDERSEN · 15,08 %
- 2024 · BJARNE BORGERSEN · 6,40 %
- 2024 · TEG HOLDING AS · 5,41 %
- 2024 · PER-ANDERS DAHLGREN · 3,97 %
- 2024 · GULSHAN ARA ISLAM · 2,27 %
- 2024 · MARIT MARKHUS · 1,88 %
- 2024 · ALF TERJE ANDRESEN · 1,59 %
- 2024 · SISSEL KIIL SAGA · 1,32 %
- 2024 · HEIDI KIIL BLOMHOFF · 1,32 %
- 2024 · SIV EIDE KALAND · 1,23 %
- 2024 · ANNE SELLEVOLD BECK · 1,01 %
- 2024 · ARNE BENGT RIPLE · 1,01 %
- 2024 · JO DØHL · 1,01 %
- 2024 · TONJE FOSSHEIM · 0,95 %
- 2024 · ANETTE NÆRUM SAUVE · 0,93 %
- 2024 · ANNE MARTE HAUG · 0,93 %
- 2024 · TORE ODIN BOLSTAD · 0,93 %
- 2024 · THOMAS BJELLAAS · 0,86 %
- 2024 · HELGE MIKAEL ANDREAS AKER · 0,78 %
- 2024 · HENRIK KIIL BLOMHOFF · 0,69 %
- 2024 · MAIA BLOMHOFF HOLM · 0,69 %
- 2024 · CHRISTIAN KIIL BRUN-PEDERSEN · 0,66 %
- 2024 · THOMAS KIIL BRUN-PEDERSEN · 0,66 %
- 2024 · WENDY SKJELLNAN · 0,51 %
- 2024 · PHARMCONSULT AS · 0,44 %
- 2024 · PER JØRGEN SØETORP WAALER · 0,37 %
- 2024 · ASTA ELINE AKER · 0,16 %
- 2024 · MARTHE FLATØ VESTBY · 0,05 %
- 2024 · NATALIA MAGDALENA DRZEWIECKA · 0,03 %
- 2024 · JOANNA IZDEBSKA · 0,03 %
- 2024 · INGA MORK AUNE · 0,01 %
- 2024 · AHMED HASSAN · 0,01 %
- 2023 · DBG AS · 24,43 %
- 2023 · REDOKS AS · 22,92 %
- 2023 · THOMAS ERIK GUNDERSEN · 15,25 %
- 2023 · BJARNE BORGERSEN · 6,47 %
- 2023 · TEG HOLDING AS · 5,63 %
- 2023 · PER-ANDERS DAHLGREN · 4,01 %
- 2023 · GULSHAN ARA ISLAM · 2,30 %
- 2023 · ALF TERJE ANDRESEN · 1,46 %
- 2023 · SISSEL KIIL SAGA · 1,34 %
- 2023 · HEIDI KIIL BLOMHOFF · 1,34 %
- 2023 · SIV EIDE KALAND · 1,24 %
- 2023 · ANNE SELLEVOLD BECK · 1,02 %
- 2023 · ARNE BENGT RIPLE · 1,02 %
- 2023 · JO DØHL · 1,02 %
- 2023 · MARIT MARKHUS · 0,96 %
- 2023 · TONJE FOSSHEIM · 0,96 %
- 2023 · ANETTE NÆRUM SAUVE · 0,94 %
- 2023 · ANNE MARTE HAUG · 0,94 %
- 2023 · TORE ODIN BOLSTAD · 0,94 %
- 2023 · HELGE MIKAEL ANDREAS AKER · 0,79 %
- 2023 · THOMAS BJELLAAS · 0,79 %
- 2023 · HENRIK KIIL BLOMHOFF · 0,70 %
- 2023 · MAIA BLOMHOFF HOLM · 0,70 %
- 2023 · CHRISTIAN KIIL BRUN-PEDERSEN · 0,67 %
- 2023 · THOMAS KIIL BRUN-PEDERSEN · 0,67 %
- 2023 · WENDY SKJELLNAN · 0,51 %
- 2023 · PHARMCONSULT AS · 0,44 %
- 2023 · PER JØRGEN SØETORP WAALER · 0,38 %
- 2023 · ASTA ELINE AKER · 0,16 %
YEAR-DATED OWNERSHIP
Company share entries
The company’s own investments in other businesses. Shareholders who own the company are shown under Ownership.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to 500 source records examined; the view may be limited. Missing matches do not prove that ownership is absent.
YEAR-DATED OWNERSHIP
Indirect ownership
Explore documented ownership paths through companies. Each path and share class is shown separately; shares are not added together.
Source and scope
Skatteetaten / Aksjonærregisteret. Every level uses the same source year and source set. Further links follow Norwegian business registration numbers; foreign identifiers are not linked automatically. Calculated share is the product of reported share count / total shares at each level, not voting rights, control, or today’s shareholder register. Partial source coverage is stated at the relevant level; unresolved calculation basis is shown without a percentage.
Up to four ownership levels, 32 company lookups, and 250 chains are examined within a short time budget. This is a limited selection, not a ranking of the largest 250. Cycles are stopped. Missing matches do not prove that ownership is absent.
CONNECTIONS
Explore the ownership structure.
Directly reported ownership entries are shown first. Open the map to explore further.
Direct ownership entries without an interactive map
As of 31 December 2025 · 10 of 35 available ownership entries
Multiple company owners (2)
| Shareholder | Share / share class | Source date |
|---|---|---|
| VAR FORVALTNING ASView ownership entryView share entries → | 0,78 % · Ordinary shares | 31.12.2025 |
| PHARMCONSULT ASView ownership entryView share entries → | 0,64 % · Ordinary shares | 31.12.2025 |
Source: Skatteetaten / Aksjonærregisteret. Year-dated share ownership is not necessarily today’s voting rights or corporate control.
Open interactive map for direct ownership entries
CONNECTIONS
Explore the ownership structure.
See owners and open further company levels, using the same year throughout the tree.
Click a company to open owners. Select i for details.